【4523】エーザイ : PHASE III TRIAL SHOWS LENVATINIB MEETS PRIMARY ENDPOINT OF PROGRESSION FREE SURVIVAL BENEFIT IN TREATMENT OF RADIOIODINE-REFRACTORY DIFFERENTIATED THY

PHASE III TRIAL SHOWS LENVATINIB MEETS PRIMARY ENDPOINT OF PROGRESSION FREE SURVIVAL BENEFIT IN TREATMENT OF RADIOIODINE-REFRACTORY DIFFERENTIATED THY

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード